Given the high prevalence of COVID19 illness (both SARS-CoV-2 RT-PCR confirmed and highly suspect cases) among healthcare workers (HCW) within the Montefiore Health System (MHS), hydroxychloroquine (HCQ) will be prescribed to healthcare workers who are at the highest risk for severe COVID19 illness.
Drug: Hydroxychloroquine
400 mg tablet
Inclusion Criteria:
- Symptomatic with COVID illness (either RT-PCR test confirmed or highly suspect
clinical symptoms)
- Call into office within the first 7 days of illness
- Have any of the following high risk conditions:
- Age >60
- HTN, CAD, or chronic heart disease
- Diabetes
- Chronic kidney disease
- Chronic lung disease
- Active or recent chemotherapy for malignancy
- Organ transplant
- Taking Immune-suppressing medications
- HIV with CD4 <200 cells/mm3
- Experiencing at least one of the following high risk symptoms:
- Severe cough
- Fever 100.0F or greater
- Diarrhea
- Shortness of Breath
- Hypoxia
Exclusion Criteria:
• HCW not meeting high-risk criteria or those with a contraindication to HCQ will not be
offered HCQ
Montefiore Medical Center
Bronx, New York, United States
Priya Nori, MD, Principal Investigator
Montefiore Medical Center